{"nct_id":"NCT05000450","title":"Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2024-06","start_date":"2021-06-06","start_date_type":"ACTUAL","primary_completion_date":"2023-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-11","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ALLO"]}